Efficacy and safety of palliative treatment in patients with autoimmune liver disease-associated hepatocellular carcinoma

In summary, this study demonstrates comparable mOS for AILD-HCC patients undergoing local and systemic treatments, with better tolerability than HCC of other causes. TKIs remain important therapeutic options for AILD-HCC patients, particularly given their exclusion from recent immunotherapy trials.

Authors

Institutions

Publication Details

Journal
Annals of Hepatology
Published
2024-08-13
DOI
https://doi.org/10.1016/j.aohep.2024.101534
Citations
2
Primary Topic
Liver Disease Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
0.77

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Efficacy and safety of palliative treatment in patients with autoimmune liver disease-associated hepatocellular carcinoma

Arndt Weinmann, Douglas Thorburn, Oliver Waidmann, George Ν. Dalekos et al.
2 citations
Annals of Hepatology
Liver Disease Diagnosis and Treatment
0.77
article

Efficacy and safety of palliative treatment in patients with autoimmune liver disease-associated hepatocellular carcinoma

Arndt Weinmann, Douglas Thorburn, Oliver Waidmann, George Ν. Dalekos, Aurélie Walter, Kornelius Schulze, Fabian Finkelmeier, Louisa Stern, Johann von Felden, Lorenz Kocheise, Vincent Joerg, Bernhard Scheiner, Constantin Schmidt, Ana Lleò, Martha M. Kirstein, Matthias Pinter, Nikolaos Gatselis, Ansgar Wilhelm Lohse, Joost P.H. Drenth, Neil Halliday, Kalliopi Zachou, Arndt Vogel, Mária Papp, Christian Casar, Henning Wege, Piotr Milkiewicz, Samuel Huber
article en
2 citations

Abstract

In summary, this study demonstrates comparable mOS for AILD-HCC patients undergoing local and systemic treatments, with better tolerability than HCC of other causes. TKIs remain important therapeutic options for AILD-HCC patients, particularly given their exclusion from recent immunotherapy trials.

Annals of HepatologyVol. 29(6)
Goethe University Frankfurt (DE), University of Debrecen (HU), Humanitas University (IT), Radboud University Nijmegen (NL), Universität Hamburg (DE), Johannes Gutenberg University Mainz (DE), The Royal Free Hospital (GB), Radboud University Medical Center (NL), Medizinische Hochschule Hannover (DE), Assistance Publique – Hôpitaux de Paris (FR), University Hospital of Larissa (GR), University Medical Center Hamburg-Eppendorf (DE), University Hospital Schleswig-Holstein (DE), Hôpital Avicenne (FR), University Hospital Frankfurt (DE), IRCCS Humanitas Research Hospital (IT), University College London (GB), Medical University of Vienna (AT), Pomeranian Medical University (PL), University of Lübeck (DE)
Wilhelm Sander-Stiftung, Deutsche Forschungsgemeinschaft, Bundesministerium für Bildung und Forschung, Deutsche Krebshilfe
Good health and well-being
Openalex Percentile: Top 26%
Liver Disease Diagnosis and Treatment
0.77
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.